Paper39129161
Immunoglobulins: Mechanistic Approaches in Moderation of Various Inflammatory and Anti-inflammatory Pathways.
Pasricha C and 5 others. Curr Pharm Biotechnol, 2025. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Immunoglobulins: Mechanistic Approaches in Moderation of Various Inflammatory and Anti-inflammatory Pathways. Papers, record 39129161. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39129161
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Immunoglobulins: Mechanistic Approaches in Moderation of Various Inflammatory and Anti-inflammatory Pathways.
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Inflammation | Major topic |
| Immunoglobulins | Major topic |
| Anti-Inflammatory Agents | Major topic |
| Humans | |
| Animals |
Source PubMed
References201
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2186517 | Antibody: the flexible adaptor molecule. | Trends Biochem Sci | 1990 | https://conductscience.org/library/papers/2186517 | PubMed |
| 2 | 37830631 | Anti-Inflammatory and Immunomodulatory Effect of High-Dose Immunoglobulins in Children: From Approved Indications to Off-Label Use. | Cells | 2023 | https://conductscience.org/library/papers/37830631 | PubMed |
| 3 | 28898770 | Immunoglobulin replacement therapy in primary and secondary antibody deficiency: The correct clinical approach. | Int Immunopharmacol | 2017 | https://conductscience.org/library/papers/28898770 | PubMed |
| 4 | 33494384 | Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33494384 | PubMed |
| 5 | 28814461 | Subcutaneous immunoglobulin in myasthenia gravis exacerbation: A prospective, open-label trial. | Neurology | 2017 | https://conductscience.org/library/papers/28814461 | PubMed |
| 6 | 25667260 | Intravenous immunoglobulin as clinical immune-modulating therapy. | CMAJ | 2015 | https://conductscience.org/library/papers/25667260 | PubMed |
| 7 | 28967695 | Intravenous immunoglobulin for the treatment of childhood encephalitis. | Cochrane Database Syst Rev | 2017 | https://conductscience.org/library/papers/28967695 | PubMed |
| 8 | 26384525 | Management of adverse events in the treatment of patients with immunoglobulin therapy: A review of evidence. | Autoimmun Rev | 2016 | https://conductscience.org/library/papers/26384525 | PubMed |
| 9 | 4162102 | Physicochemical properties of reaginic antibody. 3. Further studies on the reaginic antibody in gamma-A-globulin preparations. | J Allergy | 1966 | https://conductscience.org/library/papers/4162102 | PubMed |
| 10 | 10592235 | The Protein Data Bank. | Nucleic Acids Res | 2000 | https://conductscience.org/library/papers/10592235 | PubMed |
| 11 | 31544870 | IgG Antibody 3D Structures and Dynamics. | Antibodies (Basel) | 2018 | https://conductscience.org/library/papers/31544870 | PubMed |
| 12 | 26497515 | Fcγ receptor pathways during active and passive immunization. | Immunol Rev | 2015 | https://conductscience.org/library/papers/26497515 | PubMed |
| 13 | 26764357 | Influence of immunoglobulin isotype on therapeutic antibody function. | Blood | 2016 | https://conductscience.org/library/papers/26764357 | PubMed |
| 14 | 20041883 | The other side of immunoglobulin G: suppressor of inflammation. | Clin Exp Immunol | 2010 | https://conductscience.org/library/papers/20041883 | PubMed |
| 15 | 28951559 | Subclass-specific IgG glycosylation is associated with markers of inflammation and metabolic health. | Sci Rep | 2017 | https://conductscience.org/library/papers/28951559 | PubMed |
| 16 | 23808883 | The carbohydrate switch between pathogenic and immunosuppressive antigen-specific antibodies. | Exp Dermatol | 2013 | https://conductscience.org/library/papers/23808883 | PubMed |
| 17 | 22922409 | Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcγRIIB and dectin-1. | Nat Med | 2012 | https://conductscience.org/library/papers/22922409 | PubMed |
| 18 | 24016253 | Association between galactosylation of immunoglobulin G and improvement of rheumatoid arthritis during pregnancy is independent of sialylation. | J Proteome Res | 2013 | https://conductscience.org/library/papers/24016253 | PubMed |
| 19 | 25761865 | Skewed Fc glycosylation profiles of anti-proteinase 3 immunoglobulin G1 autoantibodies from granulomatosis with polyangiitis patients show low levels of bisection, galactosylation, and sialylation. | J Proteome Res | 2015 | https://conductscience.org/library/papers/25761865 | PubMed |
| 20 | 26200652 | Association of systemic lupus erythematosus with decreased immunosuppressive potential of the IgG glycome. | Arthritis Rheumatol | 2015 | https://conductscience.org/library/papers/26200652 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42325772 | Effects of high-dose intravenous immunoglobulin on efficacy, inflammatory markers, and pulmonary function in adults with severe acute viral pneumonia. | Am J Transl Res | 2026 | https://conductscience.org/library/papers/42325772 | PubMed |
| 40794949 | Differential causal networks highlight sex-based differences in human tissues. | Brief Bioinform | 2025 | https://conductscience.org/library/papers/40794949 | PubMed |
| 40565297 | A Novel Hybrid Peptide VLP-Aβ Efficiently Regulates Immunity by Stimulating Myeloid Differentiation Protein and Activating the NF-κB Pathway. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40565297 | PubMed |
| 40211143 | Immune status assessment based on plasma proteomics with meta graph convolutional networks. | BMC Genomics | 2025 | https://conductscience.org/library/papers/40211143 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| FCAR | 2204 | PubTator's text mining | https://conductscience.org/library/genes/2204 | NCBI Gene |
| FCGRT | 2217 | PubTator's text mining | https://conductscience.org/library/genes/2217 | NCBI Gene |
| IGHE | 3497 | PubTator's text mining | https://conductscience.org/library/genes/3497 | NCBI Gene |
| IGHG3 | 3502 | PubTator's text mining | https://conductscience.org/library/genes/3502 | NCBI Gene |
| LOC102723407 | 102723407 | PubTator's text mining | https://conductscience.org/library/genes/102723407 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39129161
GET https://conductscience.org/api/papers/v1/39129161/references?page=2